AIM2ACT for Asthma

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Asthma
AIM2ACT - Behavioral
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a new treatment for asthma in adolescents and will compare it to the current standard of care.

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: Change in baseline, post-intervention,3 months, and 6 months, and 12 month follow-up

Month 12
Asthma Control using asthma control questionnaire

Trial Safety

Trial Design

2 Treatment Groups

mHealth Attention Control Condition
1 of 2
AIM2ACT
1 of 2

Active Control

Experimental Treatment

320 Total Participants · 2 Treatment Groups

Primary Treatment: AIM2ACT · No Placebo Group · N/A

AIM2ACT
Behavioral
Experimental Group · 1 Intervention: AIM2ACT · Intervention Types: Behavioral
mHealth Attention Control Condition
Behavioral
ActiveComparator Group · 1 Intervention: mHealth Attention Control Condition · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
AIM2ACT
2015
N/A
~100

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: change in baseline, post-intervention,3 months, and 6 months, and 12 month follow-up

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,577 Previous Clinical Trials
46,968,270 Total Patients Enrolled
261 Trials studying Asthma
108,875 Patients Enrolled for Asthma
University of FloridaLead Sponsor
1,237 Previous Clinical Trials
698,165 Total Patients Enrolled
15 Trials studying Asthma
900 Patients Enrolled for Asthma
David A Fedele, Ph.D.Principal InvestigatorUniversity of Florida
2 Previous Clinical Trials
136 Total Patients Enrolled
1 Trials studying Asthma
92 Patients Enrolled for Asthma

Eligibility Criteria

Age Any Age · All Participants · 9 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
The adolescent lives in the residence of their caregiver.
The teen and caregiver can both speak and read English.
People in the age group of 12-15 are considered adolescents.
The caregiver is someone who is 18 to 70 years old.
The adolescent has been diagnosed with asthma.
in the past year An adolescent who has had an active inhaled corticosteroid prescription for more than four weeks in the past year is likely to have asthma.
An adolescent who scores nineteen or lower on the Asthma Control Test likely has uncontrolled asthma.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 13th, 2021

Last Reviewed: November 28th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.